Doctor Hiromichi Wada
NHO Kyoto Medical Centre, Kyoto (Japan)
Membership:
ESC Professional Member
Follow
Contributor content
Presentation
Lymphangiogenic factors and all-cause and cause-specific mortality and impact of chronic kidney disease on them in patients with suspected or known coronary artery disease: The EXCEED-J Study
Presentation
Growth differentiation factor 15 and all-cause and cause-specific mortality in patients with suspected or known coronary artery disease: The ANOX and EXCEED-J Studies
Presentation
Impact of diabetes on vascular endothelial growth factor D and cardiovascular mortality in patients with suspected or known coronary artery disease: the ANOX study
Presentation
Galectin-3 and cancer mortality in patients with suspected or known coronary artery disease: the ANOX study
Presentation
Impact of atrial fibrillation on soluble fms-like tyrosine kinase-1 and cardiovascular events in patients with suspected or known coronary artery disease: The EXCEED-J Study
Presentation
Impact of smoking status on the relationships of growth differentiation factor 15 with mortality and cardiovascular events in patients with suspected or known coronary artery disease: the ANOX study
Presentation
Impact of glucose tolerance status on the relationship between vascular endothelial growth factor D and mortality in patients with suspected coronary artery disease: a subanalysis of the ANOX study
Presentation
Vascular endothelial growth factor-D and mortality in suspected or known coronary heart disease patients with chronic kidney disease: a subanalysis of the ANOX study
Presentation
Diagnostic utility of biomarkers to predict coronary artery disease in patients with and without chronic kidney disease: baseline data from the EXCEED-J study
Presentation
